维普中文期刊产品整合服务
33篇 您的检索式:作者名="OFFIDANI M"
    题名 作者 年代 出处 被引量
1Thalidomide,dexamethasone and pegylated liposomal doxorubicin(ThaDD)for patients older than 65 years with newly diagnosed multiple myeloma显示文摘 Corvatta L PiersanteUi MN 2006Blood2006,108,:1
2Gemeitabinealone or combined with cisplatin in relapsed or refractory multiple myeloma显示文摘Offidani M Mele A Corvatta L 2002Leuk Lymphoma2002,43,6:1
3Common and rare side -effects of low -dose thalidomide in multiple myeloma: focus on the doseminimizing peripheral neuropathy显示文摘Offidani M Corvatta L Marconi M 2004Europ J Haematol2004,72,3:1
4Thalidomide, dexamethasone, and pegylated liposomal doxorubicin (ThaDD) for patients older than 65 years with newly diagnosed multiple myeloma 显示文摘Offidani M Corvatta L Piersantelli MN 2006Blood2006,108,7:1
5Risk assenssment of patients with hematologic malignancies who develop fever accompanied by pulmonary infiltrates:a historical cohort study显示文摘 Corvatta L Malerba L 2004Cancer2004,101,3:1
6Mucormycosis in hematologic patients显示文摘Pagano L Offidani M Fianchi L 2004Haematologica2004,89,2:1
7Risk assenssment of patients with hematologic malignancies who develop fever accompanied by pulmonary infiltrates: a historical cohort study显示文摘Offidani M Corvatta L Malerba L et ul 2004Cancer2004,101,3:1
8An evidence-based review of ixazomib citrate and its potential in the treatment of newly diagnosedmultiple myeloma显示文摘Offidani M Corvatta L Caraffa P 2014Onco Targets Ther2014,7,:1
9Common and rare side-effects of low- dose thalidomide in multiple myeloma:focus on the dose-minimizing peripheral neuropathy显示文摘Offidani M Corvatta L Marconi M 2004Eur J Haematol2004,72,6:1
10Common and rare side-effects of low-dose thalidomide in multiple myeloma: focus on the dose-minimizing peripheral neuropathy显示文摘Offidani M Corvatta L Marconi M 2004Eur J Haematol2004,72,6:1
11Common and rare sideeffects of low-dose thalidomide in multiple myeloma:focus on the dose-minimizing peripheral neuropathy显示文摘 Corvatta L Marconi M 2004Eur J Haematol2004,72,6:1
12Thalidomide, dexamethasone and pegylated liposomal doxorubicin (ThaDD) for newly diagnosed multiple myeloma patients over 65 years 显示文摘OFFIDANI M CORVATTA L PIERSANTELLI M N 2006Blood2006,108,7:1
13Mucormycosis in hematologic patients显示文摘Pagano L Offidani M Fianchi L 2004Haematologica2004,89,2:1
14Thalidomide plus oral melphalan compared with thalidomide alone for advanced multiple myeloma显示文摘Offidani M Corvatta L Marconi M 2004Hematol J2004,5,4:1
15Phase II study of melphalan, thalidomide and prednisone combined with oral panobinostat in patients with relapsed/refractory multiple myeloma 显示文摘Offidani M Polloni C Cavallo F 2012Leuk Lymphoma2012,53,9:1
16Common and rareside-effects of low-dose thalidomide in multiple myeloma : focus onthe dose-minimizing peripheral neuropathy 显示文摘Offidani M Corvatta L Marconi M 2004Eur J Haematol2004,72,6:1
17Thalidomide, dexamethasone, Doxil and Velcade (ThaDD-V) followed by consolidation/maintenance therapy in patients with relapsed- refractory multiple myeloma 显示文摘Offidani M Corvatta L Polloni C 2011Ann Hematol2011,90,12:1
18Common and rare side-effects of low-dose thalidomide in multiple myeloma:focus on the dose-minimizingperipheral neuropathy显示文摘Offidani M Corvatta L Marconi M 2004Eur J Haematol2004,72,6:1
19Technetium-99m sestamibi scintigraphy is sensitive and specific for the staging and the follow-up of patients with multiple myeloma: a multicentre study on 397 scans显示文摘Mele A Offidani M Visani G 2007Br J Haematol2007,136,:1
20Thalidomide, dexamethasone, and pegylated liposomal doxorubicin (ThaDD) for patients older than 65 years with newly diagnosed multiple myeloma 显示文摘Offidani M Corvetta L Piersantelli MN 2006Blood2006,108,7:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费